Valion Bio, Inc. Common Stock (NASDAQ:VBIO – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday, Wall Street Zen reports.
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Valion Bio, Inc. Common Stock in a report on Thursday, October 15th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Valion Bio, Inc. Common Stock currently has an average rating of “Sell”.
Read Our Latest Analysis on Valion Bio, Inc. Common Stock
Valion Bio, Inc. Common Stock Price Performance
Valion Bio, Inc. Common Stock stock opened at $0.53 on Friday. Valion Bio, Inc. Common Stock has a 52-week low of $0.47 and a 52-week high of $67.50. The firm has a fifty day moving average of $1.66 and a 200-day moving average of $13.69. The firm has a market capitalization of $471,077.00, a P/E ratio of -0.00 and a beta of 1.91. The company has a quick ratio of 0.86, a current ratio of 1.11 and a debt-to-equity ratio of 1.74.
Valion Bio, Inc. Common Stock Company Profile
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Further Reading
- Five stocks we like better than Valion Bio, Inc. Common Stock
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Valion Bio Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valion Bio Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
